Page last updated: 2024-09-03

ilomastat and Acute Radiation Syndrome

ilomastat has been researched along with Acute Radiation Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hu, BR; Huang, CQ; Li, Q; Li, XM; Pan, D; Tan, Y; Xu, MC; Zhao, BQ	1

Other Studies

1 other study(ies) available for ilomastat and Acute Radiation Syndrome

Article	Year
MMP Inhibitor Ilomastat Improves Survival of Mice Exposed to γ-Irradiation. Biomedical and environmental sciences : BES, 2018, Volume: 31, Issue:6 Topics: Acute Radiation Syndrome; Animals; Blood Cells; Dose-Response Relationship, Drug; Gamma Rays; Hydroxamic Acids; Indoles; Matrix Metalloproteinase Inhibitors; Mice; Radiation Injuries, Experimental; Radiation-Protective Agents; Spleen; Survival Analysis; Whole-Body Irradiation	2018

Article

Year

MMP Inhibitor Ilomastat Improves Survival of Mice Exposed to γ-Irradiation.

Biomedical and environmental sciences : BES, 2018, Volume: 31, Issue:6

Topics: Acute Radiation Syndrome; Animals; Blood Cells; Dose-Response Relationship, Drug; Gamma Rays; Hydroxamic Acids; Indoles; Matrix Metalloproteinase Inhibitors; Mice; Radiation Injuries, Experimental; Radiation-Protective Agents; Spleen; Survival Analysis; Whole-Body Irradiation

2018